What is Known About the Association of Antinuclear Antibodies Development During Treatment with TNF Blockers?

Por Lebwohl, Mark
Publicado em 2008

A Safety Assessment of Topical Calcineurin Inhibitors in the Treatment of Atopic Dermatitis

Por Lebwohl, Mark, Gower, Tara
Publicado em 2006

Comprehensive Literature Review of Obstetric Outcomes and Fetal Risk during Pregnancy with Pseudoxanthoma Elasticum

Por Lee, Raphael, Lebwohl, Mark
Publicado no J Clin Med (2021)

Psoriasis: Overview and Diagnosis

Por Kimmel, Grace W., Lebwohl, Mark
Publicado no Evidence-Based Psoriasis (2018)

Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis

Por Koutruba, Nora, Emer, Jason, Lebwohl, Mark
Publicado em 2010

Impact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3µg/g in Patients with Mild-to-moderate Plaque Psoriasis

Por Lebwohl, Mark, Preston, Norman, Gottschalk, Ronald W.
Publicado em 2012

IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies

Por Blauvelt, Andrew, Lebwohl, Mark G, Bissonnette, Robert
Publicado no J Invest Dermatol (2015)

Efficacy and safety of ustekinumab in adolescents

Por Kellen, Roselyn, Silverberg, Nanette B, Lebwohl, Mark
Publicado no Pediatric Health Med Ther (2016)

Reply to research letter

Por Rivera-Oyola, Ryan, Koschitzky, Merav, Lebwohl, Mark
Publicado no J Am Acad Dermatol (2020)

The Psoriasis Decision Tree

Por Monks, George, Rivera-Oyola, Ryan, Lebwohl, Mark
Publicado no J Clin Aesthet Dermatol (2021)

Should biologics for psoriasis be interrupted in the era of COVID-19?

Por Lebwohl, Mark, Rivera-Oyola, Ryan, Murrell, Dedee F.
Publicado no J Am Acad Dermatol (2020)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”

Por Murrell, Dedee F., Rivera-Oyola, Ryan, Lebwohl, Mark
Publicado no J Am Acad Dermatol (2020)

Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”

Por Lebwohl, Mark, Rivera-Oyola, Ryan, Murrell, Dedee F.
Publicado no J Am Acad Dermatol (2020)

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment a...

Por Emer, Jason J., Frankel, Amylynne, Sohn, Andrew, Lebwohl, Mark
Publicado em 2011

Pseudoxanthoma elasticum: Mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter

Por Ringpfeil, Franziska, Lebwohl, Mark G., Christiano, Angela M., Uitto, Jouni
Publicado em 2000

Infrared Camera Evaluation of the Cooling Effect of Triamcinolone Acetonide Aerosol

Por Linkner, Rita V., Sohn, Andrew, Goldenberg, Kristin A, Lebwohl, Mark
Publicado em 2013

Relationship between severity of the local skin reactions and the rate of local skin reaction resolution in patients treated with ingenol mebutate gel

Por Jim On, Shelbi C, Knudsen, Kim Mark, Skov, Torsten, Lebwohl, Mark
Publicado no Clin Cosmet Investig Dermatol (2016)

“COVID arm”: A reaction to the Moderna vaccine

Por Wei, Nancy, Fishman, Mary, Wattenberg, Debra, Gordon, Marsha, Lebwohl, Mark
Publicado no JAAD Case Rep (2021)

US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic...

Por Lebwohl, Mark G., Kavanaugh, Arthur, Armstrong, April W., Van Voorhees, Abby S.
Publicado no Am J Clin Dermatol (2015)

Malignancy Rates in Brodalumab Clinical Studies for Psoriasis

Por Gottlieb, Alice, Lebwohl, Mark, Liu, Clive, Israel, Robert J., Jacobson, Abby
Publicado no Am J Clin Dermatol (2020)